Agnieszka Sekula

Agnieszka is a scientist with a background in biomedical engineering, psychology and design. She is currently a PhD candidate at Clinical Psychedelic Lab at Monash University and a co-investigator on a psilocybin study for depression, with the goal to improve outcomes and increase access through a personalised, tech-supported design of PAT. As a scientist at Monash, she investigates mechanisms of novel therapeutics, including psychedelics and VR. As a co-founder of Enosis Therapeutics she developed a novel method of leveraging immersive technology to create an insight-focused approach to mental health treatment, well-being and human optimisation. She conducted the World’s first study on using an immersive therapeutic approach in combination with psychedelics to sustain psycho-emotional change.